ADVFN Logo ADVFN

We could not find any results for:
Make sure your spelling is correct or try broadening your search.

Trending Now

Toplists

It looks like you aren't logged in.
Click the button below to log in and view your recent history.

Hot Features

Registration Strip Icon for default Register for Free to get streaming real-time quotes, interactive charts, live options flow, and more.

CBUS Cibus Inc

9.11
-0.92 (-9.17%)
15 Jun 2024 - Closed
Delayed by 15 minutes
Share Name Share Symbol Market Type
Cibus Inc NASDAQ:CBUS NASDAQ Common Stock
  Price Change % Change Share Price Bid Price Offer Price High Price Low Price Open Price Shares Traded Last Trade
  -0.92 -9.17% 9.11 8.93 10.04 10.10 9.10 9.98 254,312 01:00:00

Cibus to Report Fourth Quarter 2023 Financial Results on March 21, 2024 and Host Conference Call

07/03/2024 12:00pm

GlobeNewswire Inc.


Cibus (NASDAQ:CBUS)
Historical Stock Chart


From Dec 2023 to Jun 2024

Click Here for more Cibus Charts.

Cibus, Inc. (Nasdaq: CBUS), a leading agricultural biotechnology company that uses proprietary gene editing technologies to develop plant traits (or specific genetic characteristics) in seeds, today announced that the company will report fourth quarter 2023 financial results on Thursday, March 21, 2024. Cibus’ management team will host a conference call and audio webcast at 4:30 p.m. ET on that day to discuss the financial results and other company updates.

Title: Cibus, Inc. Fourth Quarter 2023 Results Conference Call Event Date: Thursday, March 21, 2024Time: 4:30 p.m. ETParticipant Numbers: +1-877-704-4453 (U.S.), +1-201-389-0920 (International)Event Link: https://investor.cibus.com/events

For interested individuals unable to join the conference call, a dial-in replay of the call will be available through Thursday, April 4, 2024 and can be accessed by dialing +1-844-512-2921 (U.S.), +1-412-317-6671 (International) and entering replay passcode: 13743898.

A live audio webcast of the call, along with accompanying slides, will be available under "News & Events” in the Investor section of the Company's website, investor.cibus.com. An archived webcast will be available on the Company's website for 90 days after the event.

About Cibus Cibus is a leader in Gene Edited Productivity traits that address critical productivity and sustainability challenges for farmers such as diseases and pests which the United Nations estimates cost the global economy approximately $300 billion annually. Cibus is not a seed company. It is a technology company that uses gene editing to develop and license traits to seed companies in exchange for royalties on seed sales. Cibus’ focus is productivity traits for the major global crops such as canola, rice, soybean, and wheat. Cibus is a technology leader in high throughput gene editing technology that enables Cibus to develop and commercialize plant traits at a fraction of the time and cost of conventional breeding. Using its Trait Machine Process, Cibus has developed a pipeline of five productivity traits including important traits for pod shatter reduction, Sclerotinia resistance and weed management. Its initial traits for pod shatter reduction and weed management are developed in collaborations with leading seed companies. Its other pipeline traits including Sclerotinia resistance are in advanced greenhouse and field trial stages.

Cibus Contacts: Investor RelationsKaren Troeberktroeber@cibus.com 858-450-2636

Jeff Sonnek – ICRjeff.sonnek@icrinc.com

Media RelationsColin Sanford colin@bioscribe.com 203-918-4347

 

1 Year Cibus Chart

1 Year Cibus Chart

1 Month Cibus Chart

1 Month Cibus Chart

Your Recent History

Delayed Upgrade Clock